首页|期刊导航|中华医学杂志（英文版）|Epidermal growth factor receptor compound and concomitant mutations:advances in precision treatment strategies

Epidermal growth factor receptor compound and concomitant mutations:advances in precision treatment strategies

Wenqian Li Rilan Bai Hanfei Guo Jiuwei Cui

中华医学杂志（英文版）2023，Vol.136Issue(23)：2776-2786,11.

中华医学杂志（英文版）2023，Vol.136Issue(23)：2776-2786,11.DOI:10.1097/CM9.0000000000002548

Epidermal growth factor receptor compound and concomitant mutations:advances in precision treatment strategies

Wenqian Li ¹Rilan Bai ¹Hanfei Guo ¹Jiuwei Cui¹

作者信息

1. Department of Cancer Center,The First Hospital of Jilin University,Jilin University,Changchun,Jilin 130021,China
折叠

摘要

关键词

Epidermal growth factor receptor/Compound mutation/Concomitant mutation/Non-small cell lung cancer/Targeted therapy

Key words

Epidermal growth factor receptor/Compound mutation/Concomitant mutation/Non-small cell lung cancer/Targeted therapy

引用本文复制引用

Wenqian Li,Rilan Bai,Hanfei Guo,Jiuwei Cui..Epidermal growth factor receptor compound and concomitant mutations:advances in precision treatment strategies[J].中华医学杂志（英文版）,2023,136(23):2776-2786,11.

基金项目

This work was supported by grants from the National Natural Science Foundation of China(No.81874052),Jilin Province Health Talents Special Project(No.JLSWSRCZX2020-0023),and the Technology Develop-ment Program of Jilin Province(No.20190303146SF)to J.Cui. （No.81874052）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航